Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
William S. Loui
Observed names:
Loui, William S.,
W. S. Loui,
WILLIAM S. LOUI,
William Loui,
William S Loui
Institution:
University of Hawaii Cancer Center
Observed institutions:
Mayo Clinic,
Claremont Graduate University,
Trinity Health Ann Arbor Hospital,
Cancer Center of Kansas,
Mayo Clinic in Florida,
University of Hawaii Cancer Center
show all 6
OpenAlex ID:
A5063589088
Phase I/II Randomized Trial of Sorafenib and Bevacizumab as First-Line Therapy in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma: North Central Cancer Treatment Group Trial N0745 (Alliance)
2016
·
Joleen M. Hubbard
, Michelle R. Mahoney
, et al.
·
Targeted Oncology
·
31
Dual VEGF inhibition with sorafenib and bevacizumab as salvage therapy in metastatic colorectal cancer: results of the phase II North Central Cancer Treatment Group study N054C (Alliance)
2020
·
Hao Xie
, Jacqueline M. Lafky
, et al.
·
Therapeutic Advances in Medical Oncology
·
30
PDF
Obstructive Sleep Apnea Manifesting as Suspected Angina: Report of Three Cases
1994
·
WILLIAM S. LOUI
, JOSEPH L. BLACKSHEAR
, et al.
·
Mayo Clinic Proceedings
·
23
Dual VEGF inhibition with sorafenib and bevacizumab (BEV) as salvage therapy in metastatic colorectal cancer (mCRC): Results of the phase II North Central Cancer Treatment Group study N054C.
2010
·
A. Grothey
, J. M. Lafky
, et al.
·
Journal of Clinical Oncology
·
13
A Pilot Study to Determine the Effect of an Educational DVD in Philippine Languages on Cancer Clinical Trial Participation among Filipinos in Hawai'i.
2017
·
Jamie Q Felicitas-Perkins
, Melvin Paul Palalay
, et al.
·
PubMed
·
7
Phase I evaluation of sorafenib (SOR) and bevacizumab (BEV) as first-line therapy in hepatocellular cancer (HCC): North Central Cancer Treatment Group trial N0745.
2011
·
J. M. Hubbard
, S. R. Alberts
, et al.
·
Journal of Clinical Oncology
·
3
UH Cancer Center Hotline: addressing cancer care disparities for Filipinos in Hawai'i; a unique approach to communicating about cancer treatment.
2011
·
William S Loui
·
PubMed
·
2
Metastatic Colonic Glomus Tumor, Insights in to its Pathogenetic Mechanisms. A Case Report with Comprehensive Molecular Profiling
2019
·
Ana I Hernandez
, William Loui
, et al.
·
Acta Scientific Medical Sciences
Multigene Molecular Profiling in Nasopharyngeal Carcinoma: A Case of Monozygotic Twins.
2015
·
Qi Jie Nicholas Leo
, Christopher Lum
, et al.
·
PubMed Central
Assessing quality in a rural oncology program using the Quality Oncology Practice Initiative (QOPI).
2012
·
William S. Loui
, Bonnie Auerbach
, et al.
·
Journal of Clinical Oncology
Abstract 5562: Utility of circulating biomarkers as outcome predictors in metastatic colorectal cancer and recurrent glioblastoma multiforme patients treated with bevacizumab/sorafenib
2012
·
Jacqueline M. Lafky
, S. Keith Anderson
, et al.
·
Cancer Research
Circulating endothelial cells (CECs) in metastatic colorectal cancer (mCRC) patients (pts) treated with bevacizumab (BEV) and sorafenib.
2011
·
J. M. Lafky
, B. M. Bot
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
15
Citation count:
109
H-index:
5
I10-index:
4
Year
Topic
Type